210 related articles for article (PubMed ID: 9337349)
1. Cross-reactivity of C219 anti-p170(mdr-1) antibody with p185(c-erbB2) in breast cancer cells: cautions on evaluating p170(mdr-1).
Liu B; Sun D; Xia W; Hung MC; Yu D
J Natl Cancer Inst; 1997 Oct; 89(20):1524-9. PubMed ID: 9337349
[TBL] [Abstract][Full Text] [Related]
2. Anti-P-glycoprotein antibody C219 cross-reactivity with c-erbB2 protein: diagnostic and clinical implications.
Chan HS; Ling V
J Natl Cancer Inst; 1997 Oct; 89(20):1473-6. PubMed ID: 9337338
[No Abstract] [Full Text] [Related]
3. Antibody C219 recognizes an alpha-helical epitope on P-glycoprotein.
van Den Elsen JM; Kuntz DA; Hoedemaeker FJ; Rose DR
Proc Natl Acad Sci U S A; 1999 Nov; 96(24):13679-84. PubMed ID: 10570132
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of c-erbB-2/neu in breast cancer cells confers increased resistance to Taxol via mdr-1-independent mechanisms.
Yu D; Liu B; Tan M; Li J; Wang SS; Hung MC
Oncogene; 1996 Sep; 13(6):1359-65. PubMed ID: 8808711
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical localization in normal tissues of different epitopes in the multidrug transport protein P170: evidence for localization in brain capillaries and crossreactivity of one antibody with a muscle protein.
Thiebaut F; Tsuruo T; Hamada H; Gottesman MM; Pastan I; Willingham MC
J Histochem Cytochem; 1989 Feb; 37(2):159-64. PubMed ID: 2463300
[TBL] [Abstract][Full Text] [Related]
6. [Eukaryotic expression and biological activities of anti-p185 erbB2 mouse/human chimeric antibody].
Jiang BH; Liu WB; Meng L; Wu J; Shou CC
Beijing Da Xue Xue Bao Yi Xue Ban; 2004 Oct; 36(5):491-5. PubMed ID: 15489929
[TBL] [Abstract][Full Text] [Related]
7. A new mdr-1 encoded P-170 specific monoclonal antibody: (6/1C) on paraffin wax embedded tissue without pretreatment of sections.
Moran E; Larkin A; Doherty G; Kelehan P; Kennedy S; Clynes M
J Clin Pathol; 1997 Jun; 50(6):465-71. PubMed ID: 9378810
[TBL] [Abstract][Full Text] [Related]
8. Cell surface density of p185(c-erbB-2) determines susceptibility to anti-p185(c-erbB-2)-ricin A chain (RTA) immunotoxin therapy alone and in combination with anti-p170(EGFR)-RTA in ovarian cancer cells.
Dean GS; Pusztai L; Xu FJ; O'Briant K; DeSombre K; Conaway M; Boyer CM; Mendelsohn J; Bast RC
Clin Cancer Res; 1998 Oct; 4(10):2545-50. PubMed ID: 9796989
[TBL] [Abstract][Full Text] [Related]
9. Analysis of a novel cDNA encoding a C219-reactive peptide isolated from methotrexate-selected multidrug-resistant human leukemic cells.
Norris MD; Gilbert J; Madafiglio J; Haber M
Gene; 1995 Apr; 156(2):313-4. PubMed ID: 7758977
[TBL] [Abstract][Full Text] [Related]
10. P-glycoprotein of blood brain barrier: cross-reactivity of Mab C219 with a 190 kDa protein in bovine and rat isolated brain capillaries.
Beaulieu E; Demeule M; Pouliot JF; Averill-Bates DA; Murphy GF; Béliveau R
Biochim Biophys Acta; 1995 Jan; 1233(1):27-32. PubMed ID: 7833346
[TBL] [Abstract][Full Text] [Related]
11. Generation of a monoclonal antibody to P-glycoprotein peptides using tuberculin-PPD as a carrier.
Bashir I; Sikora K; Foster CS
Virchows Arch; 1998 Mar; 432(3):279-87. PubMed ID: 9532008
[TBL] [Abstract][Full Text] [Related]
12. Immunocytochemical detection of the p170 multidrug resistance (MDR) and the p53 tumor suppressor gene proteins in human breast cancer cells: clinical and therapeutical significance.
Bodey B; Bodey B; Gröger AM; Luck JV; Siegel SE; Taylor CR; Kaiser HE
Anticancer Res; 1997; 17(2B):1311-8. PubMed ID: 9137491
[TBL] [Abstract][Full Text] [Related]
13. Activation state-specific monoclonal antibody detects tyrosine phosphorylated p185neu/erbB-2 in a subset of human breast tumors overexpressing this receptor.
DiGiovanna MP; Stern DF
Cancer Res; 1995 May; 55(9):1946-55. PubMed ID: 7728765
[TBL] [Abstract][Full Text] [Related]
14. Heregulin and agonistic anti-p185(c-erbB2) antibodies inhibit proliferation but increase invasiveness of breast cancer cells that overexpress p185(c-erbB2): increased invasiveness may contribute to poor prognosis.
Xu FJ; Stack S; Boyer C; O'Briant K; Whitaker R; Mills GB; Yu YH; Bast RC
Clin Cancer Res; 1997 Sep; 3(9):1629-34. PubMed ID: 9815853
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of the c-erbB-2 gene enhanced intrinsic metastasis potential in human breast cancer cells without increasing their transformation abilities.
Tan M; Yao J; Yu D
Cancer Res; 1997 Mar; 57(6):1199-205. PubMed ID: 9067293
[TBL] [Abstract][Full Text] [Related]
16. Multidrug resistance P-glycoprotein monoclonal antibody JSB-1 crossreacts with pyruvate carboxylase.
Rao VV; Anthony DC; Piwnica-Worms D
J Histochem Cytochem; 1995 Dec; 43(12):1187-92. PubMed ID: 8537634
[TBL] [Abstract][Full Text] [Related]
17. Immunocytochemical observation of multidrug resistance (MDR) p170 glycoprotein expression in human osteosarcoma cells. The clinical significance of MDR protein overexpression.
Bodey B; Taylor CR; Siegel SE; Kaiser HE
Anticancer Res; 1995; 15(6B):2461-8. PubMed ID: 8669809
[TBL] [Abstract][Full Text] [Related]
18. Isoform I (mdr3) is the major form of P-glycoprotein expressed in mouse brain capillaries. Evidence for cross-reactivity of antibody C219 with an unrelated protein.
Jetté L; Pouliot JF; Murphy GF; Béliveau R
Biochem J; 1995 Feb; 305 ( Pt 3)(Pt 3):761-6. PubMed ID: 7848274
[TBL] [Abstract][Full Text] [Related]
19. Flow cytometric analysis of multidrug-resistance-associated antigen (P-glycoprotein) and DNA ploidy in human colon cancer.
Danova M; Giordano M; Erba E; Palmeri S; Candiloro V; Riccardi A; Ucci G; Mazzini G; D'Incalci M; Ascari E
J Cancer Res Clin Oncol; 1992; 118(8):575-80. PubMed ID: 1355483
[TBL] [Abstract][Full Text] [Related]
20. P-glycoprotein epitope mapping. I. Identification of a linear human-specific epitope in the fourth loop of the P-glycoprotein extracellular domain by MM4.17 murine monoclonal antibody to human multi-drug-resistant cells.
Cianfriglia M; Willingham MC; Tombesi M; Scagliotti GV; Frasca G; Chersi A
Int J Cancer; 1994 Jan; 56(1):153-60. PubMed ID: 7505264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
